2-55175863-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152385.4(CLHC1):c.1688G>A(p.Arg563Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152385.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLHC1 | NM_152385.4 | c.1688G>A | p.Arg563Gln | missense_variant | 13/13 | ENST00000401408.6 | NP_689598.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLHC1 | ENST00000401408.6 | c.1688G>A | p.Arg563Gln | missense_variant | 13/13 | 1 | NM_152385.4 | ENSP00000384869.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251188Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135738
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461716Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 727166
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.1688G>A (p.R563Q) alteration is located in exon 13 (coding exon 11) of the CLHC1 gene. This alteration results from a G to A substitution at nucleotide position 1688, causing the arginine (R) at amino acid position 563 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at